This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abdalla MY, Ahmad IM, Switzer B, Britigan BE. Induction of heme oxygenase-1 contributes to survival of Mycobacterium abscessus in human macrophages-like THP-1 cells. Redox Biol. 2015; 4:328–339. https://doi.org/10.1016/j.redox.2015.01.012AbdallaMYAhmadIMSwitzerBBritiganBE.Induction of heme oxygenase-1 contributes to survival of Mycobacterium abscessus in human macrophages-like THP-1 cells.Redox Biol.2015;4:328–339. https://doi.org/10.1016/j.redox.2015.01.012Open DOISearch in Google Scholar
Abdelaal HFM, Chan ED, Young L, Baldwin SL, Coler RN.Mycobacterium abscessus: It’s Complex. Microorganisms. 2022 Jul; 10(7):1454. https://doi.org/10.3390/microorganisms10071454AbdelaalHFMChanEDYoungLBaldwinSLColerRN.Mycobacterium abscessus: It’s Complex.Microorganisms.2022Jul;10(7):1454. https://doi.org/10.3390/microorganisms10071454Open DOISearch in Google Scholar
Bastian S, Veziris N, Roux AL, Brossier F, Gaillard JL, Jarlier V, Cambau E. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother. 2011 Feb;55(2):775–781. https://doi.org/10.1128/AAC.00861-10BastianSVezirisNRouxALBrossierFGaillardJLJarlierVCambauE.Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.Antimicrob Agents Chemother.2011Feb;55(2):775–781. https://doi.org/10.1128/AAC.00861-10Open DOISearch in Google Scholar
Bernut A, Viljoen A, Dupont C, Sapriel G, Blaise M, Bouchier C, Brosch R, de Chastellier C, Herrmann JL, Kremer L. Insights into the smooth-to-rough transitioning in Mycobacterium bolletii unravels a functional Tyr residue conserved in all mycobacterial MmpL family members. Mol Microbiol. 2016 Mar;99(5):866–883. https://doi.org/10.1111/mmi.13283BernutAViljoenADupontCSaprielGBlaiseMBouchierCBroschRde ChastellierCHerrmannJLKremerL.Insights into the smooth-to-rough transitioning in Mycobacterium bolletii unravels a functional Tyr residue conserved in all mycobacterial MmpL family members.Mol Microbiol.2016Mar;99(5):866–883. https://doi.org/10.1111/mmi.13283Open DOISearch in Google Scholar
Boeck L, Burbaud S, Skwark M, Pearson WH, Sangen J, Wuest AW, Marshall EKP, Weimann A, Everall I, Bryant JM, et al.Mycobacterium abscessus pathogenesis identified by phenogenomic analyses. Nat Microbiol. 2022 Sep;7(9):1431–1441. https://doi.org/10.1038/s41564-022-01204-xBoeckLBurbaudSSkwarkMPearsonWHSangenJWuestAWMarshallEKPWeimannAEverallIBryantJM.Mycobacterium abscessus pathogenesis identified by phenogenomic analyses.Nat Microbiol.2022Sep;7(9):1431–1441. https://doi.org/10.1038/s41564-022-01204-xOpen DOISearch in Google Scholar
Broncano-Lavado A, Senhaji-Kacha A, Santamaría-Corral G, Esteban J, García-Quintanilla M. Alternatives to antibiotics against Mycobacterium abscessus. Antibiotics. 2022 Sep;11(10):1322. https://doi.org/10.3390/antibiotics11101322Broncano-LavadoASenhaji-KachaASantamaría-CorralGEstebanJGarcía-QuintanillaM.Alternatives to antibiotics against Mycobacterium abscessus.Antibiotics.2022Sep;11(10):1322. https://doi.org/10.3390/antibiotics11101322Open DOISearch in Google Scholar
Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 2002 Oct;15(4):716–746. https://doi.org/10.1128/CMR.15.4.716-746.2002Brown-ElliottBAWallaceRJJr.Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.Clin Microbiol Rev.2002Oct;15(4):716–746. https://doi.org/10.1128/CMR.15.4.716-746.2002Open DOISearch in Google Scholar
Cho YJ, Yi H, Chun J, Cho SN, Daley CL, Koh WJ, Shin SJ. The genome sequence of ‘Mycobacterium massiliense’ strain CIP 108297 suggests the independent taxonomic status of the Mycobacterium abscessus complex at the subspecies level. PLoS One. 2013 Nov; 8(11):e81560. https://doi.org/10.1371/journal.pone.0081560ChoYJYiHChunJChoSNDaleyCLKohWJShinSJ.The genome sequence of ‘Mycobacterium massiliense’ strain CIP 108297 suggests the independent taxonomic status of the Mycobacterium abscessus complex at the subspecies level.PLoS One.2013Nov;8(11):e81560. https://doi.org/10.1371/journal.pone.0081560Open DOISearch in Google Scholar
Choi H, Kim SY, Kim DH, Huh HJ, Ki CS, Lee NY, Lee SH, Shin S, Shin SJ, Daley CL, et al. Clinical characteristics and treatment outcomes of patients with acquired macrolide-resistant Mycobacterium abscessus lung disease. Antimicrob Agents Chemother. 2017 Sep;61(10):e01146–17. https://doi.org/10.1128/AAC.01146-17ChoiHKimSYKimDHHuhHJKiCSLeeNYLeeSHShinSShinSJDaleyCL.Clinical characteristics and treatment outcomes of patients with acquired macrolide-resistant Mycobacterium abscessus lung disease.Antimicrob Agents Chemother.2017Sep;61(10):e01146–17. https://doi.org/10.1128/AAC.01146-17Open DOISearch in Google Scholar
Choo SW, Wee WY, Ngeow YF, Mitchell W, Tan JL, Wong GJ, Zhao Y, Xiao J. Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potential. Sci Rep. 2014 Feb;4:4061. https://doi.org/10.1038/srep04061ChooSWWeeWYNgeowYFMitchellWTanJLWongGJZhaoYXiaoJ.Genomic reconnaissance of clinical isolates of emerging human pathogen Mycobacterium abscessus reveals high evolutionary potential.Sci Rep.2014Feb;4:4061. https://doi.org/10.1038/srep04061Open DOISearch in Google Scholar
CLSI. Performance standards for susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes. 1st ed. CLSI supplement M62. Wayne (USA): Clinical and Laboratory Standards Institute; 2018b.CLSI.Performance standards for susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes.1st ed. CLSI supplement M62.Wayne (USA):Clinical and Laboratory Standards Institute;2018b.Search in Google Scholar
CLSI. Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes. 3rd ed. CLSI standard M24. Wayne (USA): Clinical and Laboratory Standards Institute; 2018a.CLSI.Susceptibility testing of mycobacteria, Nocardia spp., and other aerobic actinomycetes.3rd ed. CLSI standard M24.Wayne (USA):Clinical and Laboratory Standards Institute;2018a.Search in Google Scholar
da Silva PE, Von Groll A, Martin A, Palomino JC. Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol. 2011 Oct;63(1):1–9. https://doi.org/10.1111/j.1574-695X.2011.00831.xda SilvaPEVon GrollAMartinAPalominoJC.Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis.FEMS Immunol Med Microbiol.2011Oct;63(1):1–9. https://doi.org/10.1111/j.1574-695X.2011.00831.xOpen DOISearch in Google Scholar
Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, Böttger EC, Brozek J, Griffith DE, Guglielmetti L, et al. Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020 Jul;56(1):2000535. https://doi.org/10.1183/13993003.00535-2020DaleyCLIaccarinoJMLangeCCambauEWallaceRJJrAndrejakCBöttgerECBrozekJGriffithDEGuglielmettiL.Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS/ERS/ESCMID/IDSA clinical practice guideline.Eur Respir J.2020Jul;56(1):2000535. https://doi.org/10.1183/13993003.00535-2020Open DOISearch in Google Scholar
Degiacomi G, Sammartino JC, Chiarelli LR, Riabova O, Makarov V, Pasca MR.Mycobacterium abscessus, an emerging and worrisome pathogen among cystic fibrosis patients. Int J Mol Sci. 2019 Nov; 20(23):5868. https://doi.org/10.3390/ijms20235868DegiacomiGSammartinoJCChiarelliLRRiabovaOMakarovVPascaMR.Mycobacterium abscessus, an emerging and worrisome pathogen among cystic fibrosis patients.Int J Mol Sci.2019Nov;20(23):5868. https://doi.org/10.3390/ijms20235868Open DOISearch in Google Scholar
Esther CR Jr, Esserman DA, Gilligan P, Kerr A, Noone PG. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros. 2010 Mar;9(2):117–123. https://doi.org/10.1016/j.jcf.2009.12.001EstherCRJrEssermanDAGilliganPKerrANoonePG.Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.J Cyst Fibros.2010Mar;9(2):117–123. https://doi.org/10.1016/j.jcf.2009.12.001Open DOISearch in Google Scholar
Floto RA, Olivier KN, Saiman L, Daley CL, Herrmann JL, Nick JA, Noone PG, Bilton D, Corris P, Gibson RL, et al.; US Cystic Fibrosis Foundation and European Cystic Fibrosis Society. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax. 2016 Jan;71(Suppl 1): i1–22. https://doi.org/10.1136/thoraxjnl-2015-207360FlotoRAOlivierKNSaimanLDaleyCLHerrmannJLNickJANoonePGBiltonDCorrisPGibsonRLUS Cystic Fibrosis Foundation and European Cystic Fibrosis Society.; .US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis.Thorax.2016Jan;71(Suppl 1): i1–22. https://doi.org/10.1136/thoraxjnl-2015-207360Open DOISearch in Google Scholar
GenoType NTM-DR. Molecular genetic assay for detection of resistance to macrolides and aminoglycosides in various nontuberculous mycobacterial species (NTM) from cultured material. Geno-Type NTM-DR VER 1.0 Instructions for use (IFU-297-03). Nehren (Germany): Hain Lifescience GmbH; 2015. p. 4–9.GenoType NTM-DR.Molecular genetic assay for detection of resistance to macrolides and aminoglycosides in various nontuberculous mycobacterial species (NTM) from cultured material. Geno-Type NTM-DR VER 1.0 Instructions for use (IFU-297-03).Nehren (Germany):Hain Lifescience GmbH;2015. p.4–9.Search in Google Scholar
Harada T, Akiyama Y, Kurashima A, Nagai H, Tsuyuguchi K, Fujii T, Yano S, Shigeto E, Kuraoka T, Kajiki A, et al. Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol. 2012 Nov;50(11):3556–3561. https://doi.org/10.1128/JCM.01175-12HaradaTAkiyamaYKurashimaANagaiHTsuyuguchiKFujiiTYanoSShigetoEKuraokaTKajikiA.Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases.J Clin Microbiol.2012Nov;50(11):3556–3561. https://doi.org/10.1128/JCM.01175-12Open DOISearch in Google Scholar
Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, et al.; Non-tuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: An NTM-NET collaborative study. Eur Respir J. 2013 Dec;42(6):1604–1613. https://doi.org/10.1183/09031936.00149212HoefslootWvan IngenJAndrejakCAngebyKBauriaudRBemerPBeylisNBoereeMJCachoJChihotaVNon-tuberculous Mycobacteria Network European Trials Group.; .The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: An NTM-NET collaborative study.Eur Respir J.2013Dec;42(6):1604–1613. https://doi.org/10.1183/09031936.00149212Open DOISearch in Google Scholar
Honda JR, Virdi R, Chan ED. Global environmental nontuberculous mycobacteria and their contemporaneous man-made and natural niches. Front Microbiol. 2018 Aug;9:2029. https://doi.org/10.3389/fmicb.2018.02029HondaJRVirdiRChanED.Global environmental nontuberculous mycobacteria and their contemporaneous man-made and natural niches.Front Microbiol.2018Aug;9:2029. https://doi.org/10.3389/fmicb.2018.02029Open DOISearch in Google Scholar
Howard ST. Recent progress towards understanding genetic variation in the Mycobacterium abscessus complex. Tuberculosis. 2013 Dec;93(Suppl):S15–S20. https://doi.org/10.1016/S1472-9792(13)70005-2HowardST.Recent progress towards understanding genetic variation in the Mycobacterium abscessus complex.Tuberculosis.2013Dec;93(Suppl):S15–S20. https://doi.org/10.1016/S1472-9792(13)70005-2Open DOISearch in Google Scholar
ISO 20776-1:2019. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. Geneva (Switzerland): International Organization for Standardization; 2019.ISO 20776-1:2019.Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices.Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases.Geneva (Switzerland):International Organization for Standardization;2019.Search in Google Scholar
Jang MA, Koh WJ, Huh HJ, Kim SY, Jeon K, Ki CS, Lee NY. Distribution of nontuberculous mycobacteria by multigene sequencebased typing and clinical significance of isolated strains. J Clin Microbiol. 2014 Apr;52(4):1207–1212. https://doi.org/10.1128/JCM.03053-13JangMAKohWJHuhHJKimSYJeonKKiCSLeeNY.Distribution of nontuberculous mycobacteria by multigene sequencebased typing and clinical significance of isolated strains.J Clin Microbiol.2014Apr;52(4):1207–1212. https://doi.org/10.1128/JCM.03053-13Open DOISearch in Google Scholar
Jönsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol. 2007 May; 45(5):1497–1504. https://doi.org/10.1128/JCM.02592-06JönssonBEGilljamMLindbladARidellMWoldAEWelinder-OlssonC.Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.J Clin Microbiol.2007May;45(5):1497–1504. https://doi.org/10.1128/JCM.02592-06Open DOISearch in Google Scholar
Kalaiarasan E, Thangavelu K, Krishnapriya K, Muthuraj M, Jose M, Joseph NM. Diagnostic performance of real time PCR and MALDI-TOF in the detection of nontuberculous mycobacteria from clinical isolates. Tuberculosis. 2020 Dec;125:101988. https://doi.org/10.1016/j.tube.2020.101988KalaiarasanEThangaveluKKrishnapriyaKMuthurajMJoseMJosephNM.Diagnostic performance of real time PCR and MALDI-TOF in the detection of nontuberculous mycobacteria from clinical isolates.Tuberculosis.2020Dec;125:101988. https://doi.org/10.1016/j.tube.2020.101988Open DOISearch in Google Scholar
Kam JY, Hortle E, Krogman E, Warner SE, Wright K, Luo K, Cheng T, Manuneedhi Cholan P, Kikuchi K, Triccas JA, et al. Rough and smooth variants of Mycobacterium abscessus are differentially controlled by host immunity during chronic infection of adult zebrafish. Nat Commun. 2022 Feb 17;13(1):952. https://doi.org/10.1038/s41467-022-28638-5KamJYHortleEKrogmanEWarnerSEWrightKLuoKChengTManuneedhi CholanPKikuchiKTriccasJA.Rough and smooth variants of Mycobacterium abscessus are differentially controlled by host immunity during chronic infection of adult zebrafish.Nat Commun.2022Feb17;13(1):952. https://doi.org/10.1038/s41467-022-28638-5Open DOISearch in Google Scholar
Kavaliunaite E, Harris KA, Aurora P, Dixon G, Shingadia D, Muthialu N, Spencer H. Outcome according to subspecies following lung transplantation in cystic fibrosis pediatric patients infected with Mycobacterium abscessus. Transpl Infect Dis. 2020 Jun; 22(3):e13274. https://doi.org/10.1111/tid.13274KavaliunaiteEHarrisKAAuroraPDixonGShingadiaDMuthialuNSpencerH.Outcome according to subspecies following lung transplantation in cystic fibrosis pediatric patients infected with Mycobacterium abscessus.Transpl Infect Dis.2020Jun;22(3):e13274. https://doi.org/10.1111/tid.13274Open DOISearch in Google Scholar
Koh WJ, Jeon K, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Shin SJ, Huitt GA, et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med. 2011 Feb;183(3):405–410. https://doi.org/10.1164/rccm.201003-0395OCKohWJJeonKLeeNYKimBJKookYHLeeSHParkYKKimCKShinSJHuittGA.Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.Am J Respir Crit Care Med.2011Feb;183(3):405–410. https://doi.org/10.1164/rccm.201003-0395OCOpen DOISearch in Google Scholar
Leao SC, Tortoli E, Viana-Niero C, Ueki SY, Lima KV, Lopes ML, Yubero J, Menendez MC, Garcia MJ. Characterization of mycobacteria from a major Brazilian outbreak suggests that revision of the taxonomic status of members of the Mycobacterium chelonae-M. abscessus group is needed. J Clin Microbiol. 2009 Sep;47(9):2691–2698. https://doi.org/10.1128/JCM.00808-09LeaoSCTortoliEViana-NieroCUekiSYLimaKVLopesMLYuberoJMenendezMCGarciaMJ.Characterization of mycobacteria from a major Brazilian outbreak suggests that revision of the taxonomic status of members of the Mycobacterium chelonae-M. abscessus group is needed.J Clin Microbiol.2009Sep;47(9):2691–2698. https://doi.org/10.1128/JCM.00808-09Open DOISearch in Google Scholar
Leard LE, Holm AM, Valapour M, Glanville AR, Attawar S, Aversa M, Campos SV, Christon LM, Cypel M, Dellgren G, et al. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2021 Nov;40(11):1349–1379. https://doi.org/10.1016/j.healun.2021.07.005LeardLEHolmAMValapourMGlanvilleARAttawarSAversaMCamposSVChristonLMCypelMDellgrenG.Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation.J Heart Lung Transplant.2021Nov;40(11):1349–1379. https://doi.org/10.1016/j.healun.2021.07.005Open DOISearch in Google Scholar
Li H, Mulati G, Shang Y, Yao C, Wang Y, Ren W, Xue Z, Li S, Pang Y. Rapid detection of clarithromycin and amikacin resistance in Mycobacterium abscessus complex by high-resolution melting curve analysis. Microbiol Spectr. 2022 Jun;10(3):e0057422. https://doi.org/10.1128/spectrum.00574-22LiHMulatiGShangYYaoCWangYRenWXueZLiSPangY.Rapid detection of clarithromycin and amikacin resistance in Mycobacterium abscessus complex by high-resolution melting curve analysis.Microbiol Spectr.2022Jun;10(3):e0057422. https://doi.org/10.1128/spectrum.00574-22Open DOISearch in Google Scholar
Luo L, Li B, Chu H, Huang D, Zhang Z, Zhang J, Gui T, Xu L, Zhao L, Sun X, et al. Characterization of Mycobacterium Abscessus subtypes in Shanghai of China: Drug sensitivity and bacterial epidemicity as well as clinical manifestations. Medicine (Baltimore). 2016 Jan;95(3):e2338. https://doi.org/10.1097/MD.0000000000002338LuoLLiBChuHHuangDZhangZZhangJGuiTXuLZhaoLSunX.Characterization of Mycobacterium Abscessus subtypes in Shanghai of China: Drug sensitivity and bacterial epidemicity as well as clinical manifestations.Medicine (Baltimore).2016Jan;95(3):e2338. https://doi.org/10.1097/MD.0000000000002338Open DOISearch in Google Scholar
Luthra S, Rominski A, Sander P. The role of antibiotic-target-modifying and antibiotic-modifying enzymes in Mycobacterium abscessus drug resistance. Front Microbiol. 2018 Sep;9:2179. https://doi.org/10.3389/fmicb.2018.02179LuthraSRominskiASanderP.The role of antibiotic-target-modifying and antibiotic-modifying enzymes in Mycobacterium abscessus drug resistance.Front Microbiol.2018Sep;9:2179. https://doi.org/10.3389/fmicb.2018.02179Open DOISearch in Google Scholar
Mase A, Yamaguchi F, Funaki T, Yamazaki Y, Shikama Y, Fukuchi K. PCR amplification of the erm(41) gene can be used to predict the sensitivity of Mycobacterium abscessus complex strains to clarithromycin. Exp Ther Med. 2020 Feb;19(2):945–955. https://doi.org/10.3892/etm.2019.8289MaseAYamaguchiFFunakiTYamazakiYShikamaYFukuchiK.PCR amplification of the erm(41) gene can be used to predict the sensitivity of Mycobacterium abscessus complex strains to clarithromycin.Exp Ther Med.2020Feb;19(2):945–955. https://doi.org/10.3892/etm.2019.8289Open DOISearch in Google Scholar
Medjahed H, Gaillard JL, Reyrat JM.Mycobacterium abscessus: A new player in the mycobacterial field. Trends Microbiol. 2010 Mar;18(3):117–123. https://doi.org/10.1016/j.tim.2009.12.007MedjahedHGaillardJLReyratJM.Mycobacterium abscessus: A new player in the mycobacterial field.Trends Microbiol.2010Mar;18(3):117–123. https://doi.org/10.1016/j.tim.2009.12.007Open DOISearch in Google Scholar
Medjahed H, Reyrat JM. Construction of Mycobacterium abscessus defined glycopeptidolipid mutants: Comparison of genetic tools. Appl Environ Microbiol. 2009 Mar;75(5):1331–1338. https://doi.org/10.1128/AEM.01914-08MedjahedHReyratJM.Construction of Mycobacterium abscessus defined glycopeptidolipid mutants: Comparison of genetic tools.Appl Environ Microbiol.2009Mar;75(5):1331–1338. https://doi.org/10.1128/AEM.01914-08Open DOISearch in Google Scholar
Meehan CJ, Barco RA, Loh YE, Cogneau S, Rigouts L. Reconstituting the genus Mycobacterium. Int J Syst Evol Microbiol. 2021 Sep;71(9):004922. https://doi.org/10.1099/ijsem.0.004922MeehanCJBarcoRALohYECogneauSRigoutsL.Reconstituting the genus Mycobacterium.Int J Syst Evol Microbiol.2021Sep;71(9):004922. https://doi.org/10.1099/ijsem.0.004922Open DOISearch in Google Scholar
Mudde SE, Schildkraut JA, Ammerman NC, de Vogel CP, de Steenwinkel JEM, van Ingen J, Bax HI. Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: The potential role of efflux pumps. J Glob Antimicrob Resist. 2022 Dec;31:345–352. https://doi.org/10.1016/j.jgar.2022.10.015MuddeSESchildkrautJAAmmermanNCde VogelCPde SteenwinkelJEMvan IngenJBaxHI.Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: The potential role of efflux pumps.J Glob Antimicrob Resist.2022Dec;31:345–352. https://doi.org/10.1016/j.jgar.2022.10.015Open DOISearch in Google Scholar
Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009 Apr;53(4):1367–1376. https://doi.org/10.1128/AAC.01275-08NashKABrown-ElliottBAWallaceRJJr.A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.Antimicrob Agents Chemother.2009Apr;53(4):1367–1376. https://doi.org/10.1128/AAC.01275-08Open DOISearch in Google Scholar
Nessar R, Reyrat JM, Murray A, Gicquel B. Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus. J Antimicrob Chemother. 2011 Aug; 66(8):1719–1724. https://doi.org/10.1093/jac/dkr209NessarRReyratJMMurrayAGicquelB.Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus.J Antimicrob Chemother.2011Aug;66(8):1719–1724. https://doi.org/10.1093/jac/dkr209Open DOISearch in Google Scholar
Nishiuchi Y, Iwamoto T, Maruyama F. Infection sources of a common non-tuberculous mycobacterial pathogen, Mycobacterium avium complex. Front Med (Lausanne). 2017 Mar;4:27. Published 2017 Mar 7. https://doi.org/10.3389/fmed.2017.00027NishiuchiYIwamotoTMaruyamaF.Infection sources of a common non-tuberculous mycobacterial pathogen, Mycobacterium avium complex.Front Med (Lausanne).2017Mar;4:27.Published 2017 Mar 7. https://doi.org/10.3389/fmed.2017.00027Open DOISearch in Google Scholar
Qvist T, Gilljam M, Jönsson B, Taylor-Robinson D, Jensen-Fangel S, Wang M, Svahn A, Kötz K, Hansson L, Hollsing A, et al.; Scandinavian Cystic Fibrosis Study Consortium (SCFSC). Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. J Cyst Fibros. 2015 Jan;14(1):46–52. https://doi.org/10.1016/j.jcf.2014.08.002QvistTGilljamMJönssonBTaylor-RobinsonDJensen-FangelSWangMSvahnAKötzKHanssonLHollsingAScandinavian Cystic Fibrosis Study Consortium (SCFSC).;.Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia.J Cyst Fibros.2015Jan;14(1):46–52. https://doi.org/10.1016/j.jcf.2014.08.002Open DOISearch in Google Scholar
Qvist T, Pressler T, Høiby N, Katzenstein TL. Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis. Respir Res. 2014 Apr;15(1):41. https://doi.org/10.1186/1465-9921-15-41QvistTPresslerTHøibyNKatzensteinTL.Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.Respir Res.2014Apr;15(1):41. https://doi.org/10.1186/1465-9921-15-41Open DOISearch in Google Scholar
Rollet-Cohen V, Roux AL, Le Bourgeois M, Sapriel G, El Bahri M, Jais JP, Heym B, Mougari F, Raskine L, Véziris N, et al.Mycobacterium bolletii lung disease in cystic fibrosis. Chest. 2019 Aug;156(2): 247–254. https://doi.org/10.1016/j.chest.2019.03.019Rollet-CohenVRouxALLe BourgeoisMSaprielGEl BahriMJaisJPHeymBMougariFRaskineLVézirisN.Mycobacterium bolletii lung disease in cystic fibrosis.Chest.2019Aug;156(2):247–254. https://doi.org/10.1016/j.chest.2019.03.019Open DOISearch in Google Scholar
Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, Chiron R, Fauroux B, Le Bourgeois M, Munck A, et al.; OMA group. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. J Cyst Fibros. 2015 Jan;14(1):63–69. https://doi.org/10.1016/j.jcf.2014.07.004RouxALCatherinotESoismierNHeymBBellisGLemonnierLChironRFaurouxBLe BourgeoisMMunckAOMA group.; .Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.J Cyst Fibros.2015Jan;14(1):63–69. https://doi.org/10.1016/j.jcf.2014.07.004Open DOISearch in Google Scholar
Roux AL, Viljoen A, Bah A, Simeone R, Bernut A, Laencina L, Deramaudt T, Rottman M, Gaillard JL, Majlessi L, et al. The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Open Biol. 2016 Nov;6(11):160185. https://doi.org/10.1098/rsob.160185RouxALViljoenABahASimeoneRBernutALaencinaLDeramaudtTRottmanMGaillardJLMajlessiL.The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages.Open Biol.2016Nov;6(11):160185. https://doi.org/10.1098/rsob.160185Open DOISearch in Google Scholar
Schiff HF, Jones S, Achaiah A, Pereira A, Stait G, Green B. Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital. Sci Rep. 2019 Feb;9(1):1730. https://doi.org/10.1038/s41598-018-37350-8SchiffHFJonesSAchaiahAPereiraAStaitGGreenB.Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital.Sci Rep.2019Feb;9(1):1730. https://doi.org/10.1038/s41598-018-37350-8Open DOISearch in Google Scholar
Soroka D, Dubée V, Soulier-Escrihuela O, Cuinet G, Hugonnet JE, Gutmann L, Mainardi JL, Arthur M. Characterization of broadspectrum Mycobacterium abscessus class A β-lactamase. J Antimicrob Chemother. 2014 Mar;69(3):691–696. https://doi.org/10.1093/jac/dkt410SorokaDDubéeVSoulier-EscrihuelaOCuinetGHugonnetJEGutmannLMainardiJLArthurM.Characterization of broadspectrum Mycobacterium abscessus class A β-lactamase.J Antimicrob Chemother.2014Mar;69(3):691–696. https://doi.org/10.1093/jac/dkt410Open DOISearch in Google Scholar
Stout JE, Koh WJ, Yew WW. Update on pulmonary disease due to non-tuberculous mycobacteria. Int J Infect Dis. 2016 Apr;45:123–134. https://doi.org/10.1016/j.ijid.2016.03.006StoutJEKohWJYewWW.Update on pulmonary disease due to non-tuberculous mycobacteria.Int J Infect Dis.2016Apr;45:123–134. https://doi.org/10.1016/j.ijid.2016.03.006Open DOISearch in Google Scholar
Victoria L, Gupta A, Gómez JL, Robledo J.Mycobacterium abscessus complex: A review of recent developments in an emerging pathogen. Front Cell Infect Microbiol. 2021 Apr;11:659997. https://doi.org/10.3389/fcimb.2021.659997VictoriaLGuptaAGómezJLRobledoJ.Mycobacterium abscessus complex: A review of recent developments in an emerging pathogen.Front Cell Infect Microbiol.2021Apr;11:659997. https://doi.org/10.3389/fcimb.2021.659997Open DOISearch in Google Scholar
Wallace RJ Jr, Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, Böttger EC. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother. 1996 Jul;40(7):1676–1681. https://doi.org/10.1128/AAC.40.7.1676WallaceRJJrMeierABrownBAZhangYSanderPOnyiGOBöttgerEC.Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus.Antimicrob Agents Chemother.1996Jul;40(7):1676–1681. https://doi.org/10.1128/AAC.40.7.1676Open DOISearch in Google Scholar
Wassilew N, Hoffmann H, Andrejak C, Lange C. Pulmonary disease caused by non-tuberculous mycobacteria. Respiration. 2016; 91(5):386–402. https://doi.org/10.1159/000445906WassilewNHoffmannHAndrejakCLangeC.Pulmonary disease caused by non-tuberculous mycobacteria.Respiration.2016;91(5):386–402. https://doi.org/10.1159/000445906Open DOISearch in Google Scholar